Version history

{
  "session_id": "sess_SDA-2026-04-07-gap-pubmed-20260406-062150-387cb0ba_task_9aae8fc5",
  "round_number": 4,
  "agent_persona": "persona-synthesizer",
  "agent_backend": "scidex.core.llm.complete",
  "action": "synthesize",
  "content": "```json\n{\n  \"ranked_hypotheses\": [\n    {\n      \"title\": \"Spatiotemporal coupling between TRPML1-mediated lysosomal calcium release and calcineurin nanodomain activation\",\n      \"description\": \"Trehalose-induced LMP preferentially releases lysosomal Ca2+ through mucolipin-1 (TRPML1) channels, creating localized Ca2+ microdomains with sustained kinetics that selectively activate calcineurin over CaMK family members. Calcineurin exhibits high affinity for sustained Ca2+/calmodulin signals and may be spatially enriched near lysosomal membranes via AKAP proteins or direct TRPML1 interaction. However, channel redundancy (TPC1-3, TRPML1-3) remains an unresolved confounding variable requiring multi-knockout validation.\",\n      \"target_gene\": \"TRPML1/MCOLN1\",\n      \"dimension_scores\": {\n        \"evidence_strength\": 0.65,\n        \"novelty\": 0.70,\n        \"feasibility\": 0.72,\n        \"therapeutic_potential\": 0.78,\n        \"mechanistic_plausibility\": 0.68,\n        \"druggability\": 0.80,\n        \"safety_profile\": 0.55,\n        \"competitive_landscape\": 0.75,\n        \"data_availability\": 0.70,\n        \"reproducibility\": 0.72\n      },\n      \"composite_score\": 0.705,\n      \"evidence_for\": [\n        {\"claim\": \"TRPML1 mutations cause lysosomal storage disorders with impaired autophagy\", \"pmid\": \"29155873\"},\n        {\"claim\": \"Calcineurin exhibits high affinity for sustained Ca2+/calmodulin signals versus transient high-frequency signals\", \"pmid\": \"24613340\"},\n        {\"claim\": \"AKAP proteins scaffold calcineurin to specific subcellular compartments\", \"pmid\": \"28701342\"},\n        {\"claim\": \"Lysosomal Ca2+ release via TPC/TRPML channels activates calcineurin-NFAT signaling\", \"pmid\": \"28481357\"}\n      ],\n      \"evidence_against\": [\n        {\"claim\": \"Trehalose-induced LMP likely releases Ca2+ through multiple channels; TRPML1 attribution is underdetermined\", \"pmid\": \"\"},\n        {\"claim\": \"TRPML1 agonists do not fully phenocopy trehalose for TFEB activation\", \"pmid\": \"\"},\n        {\"claim\": \"Other LMP triggers do not robustly activate calcineurin despite similar Ca2+ kinetics\", \"pmid\": \"\"}\n      ]\n    },\n    {\n      \"title\": \"Calmodulin isoform switching from CaMK to calcineurin activation upon lysosomal permeabilization\",\n      \"description\": \"Global cytosolic Ca2+ elevation from LMP exceeds threshold that depletes calmodulin availability for high-affinity CaMKs, leaving residual calmodulin to bind and activate lower-affinity calcineurin. The unique calmodulin isoform composition near lysosomes determines signaling outcome toward TFEB rather than general autophagy inhibition. Indirect targeting via CaMK2 inhibitors could shift signaling toward calcineurin when combined with lysosomal calcium elevation.\",\n      \"target_gene\": \"CALM1/CALM2/CALM3\",\n      \"dimension_scores\": {\n        \"evidence_strength\": 0.58,\n        \"novelty\": 0.75,\n        \"feasibility\": 0.60,\n        \"therapeutic_potential\": 0.65,\n        \"mechanistic_plausibility\": 0.62,\n        \"druggability\": 0.50,\n        \"safety_profile\": 0.45,\n        \"competitive_landscape\": 0.70,\n        \"data_availability\": 0.62,\n        \"reproducibility\": 0.60\n      },\n      \"composite_score\": 0.607,\n      \"evidence_for\": [\n        {\"claim\": \"Calmodulin has distinct affinities for different targets based on isoform and localization\", \"pmid\": \"25454361\"},\n        {\"claim\": \"Lysosomal calcium release specifically activates calcineurin-NFAT over CaMK pathways\", \"pmid\": \"28481357\"},\n        {\"claim\": \"Calmodulin availability limits kinase vs. phosphatase activation in different Ca2+ regimes\", \"pmid\": \"29800551\"}\n      ],\n      \"evidence_against\": [\n        {\"claim\": \"Direct calmodulin targeting is toxic due to essential ubiquitous expression\", \"pmid\": \"\"},\n        {\"claim\": \"Isoform selectivity for CALM1/2/3 is challenging with current chemical matter\", \"pmid\": \"\"}\n      ]\n    },\n    {\n      \"title\": \"mTORC1 displacement from lysosomal surface enables calcineurin access to TFEB\",\n      \"description\": \"Trehalose-induced LMP disrupts the lysosomal mTORC1 complex through v-ATPase inhibition, causing TFEB release from lysosomal membranes into the cytosol where it becomes accessible to calcineurin-mediated dephosphorylation. mTORC1 normally phosphorylates TFEB at S211, preventing nuclear translocation. Specificity arises from coincident detection: calcineurin is activated by Ca2+ while TFEB is simultaneously available as substrate after mTORC1 displacement.\",\n      \"target_gene\": \"mTOR/FRAP1\",\n      \"dimension_scores\": {\n        \"evidence_strength\": 0.55,\n        \"novelty\": 0.55,\n        \"feasibility\": 0.72,\n        \"therapeutic_potential\": 0.75,\n        \"mechanistic_plausibility\": 0.60,\n        \"druggability\": 0.75,\n        \"safety_profile\": 0.50,\n        \"competitive_landscape\": 0.80,\n        \"data_availability\": 0.68,\n        \"reproducibility\": 0.70\n      },\n      \"composite_score\": 0.650,\n      \"evidence_for\": [\n        {\"claim\": \"Trehalose inhibits mTORC1 signaling\", \"pmid\": \"30335591\"},\n        {\"claim\": \"TFEB S211 phosphorylation by mTORC1 prevents nuclear translocation\", \"pmid\": \"\"},\n        {\"claim\": \"Calcineurin dephosphorylates TFEB upon mTORC1 dissociation\", \"pmid\": \"\"}\n      ],\n      \"evidence_against\": [\n        {\"claim\": \"Mechanism remains incompletely articulated in source debate\", \"pmid\": \"\"},\n        {\"claim\": \"Does not fully explain calcium specificity of the response\", \"pmid\": \"\"}\n      ]\n    },\n    {\n      \"title\": \"Reticulocalbin-2 bridges calcineurin to lysosomal membranes for Ca2+-dependent activation\",\n      \"description\": \"Reticulocalbin-2 (RCN2/ERC55), an EF-hand calcium-binding protein with ER retention, may translocate to lysosomes during trehalose-induced permeabilization, bringing calcineurin into proximity with lysosomal Ca2+ stores. The hypothesis is significantly weakened by evidence that RCN2 myristoylation targets plasma membrane rather than lysosomes, and that functional redundancy with other EF-hand proteins likely compensates for RCN2 loss.\",\n      \"target_gene\": \"RCN2\",\n      \"dimension_scores\": {\n        \"evidence_strength\": 0.35,\n        \"novelty\": 0.60,\n        \"feasibility\": 0.25,\n        \"therapeutic_potential\": 0.30,\n        \"mechanistic_plausibility\": 0.32,\n        \"druggability\": 0.20,\n        \"safety_profile\": 0.35,\n        \"competitive_landscape\": 0.65,\n        \"data_availability\": 0.40,\n        \"reproducibility\": 0.38\n      },\n      \"composite_score\": 0.360,\n      \"evidence_for\": [\n        {\"claim\": \"RCN2 is an EF-hand calcium-binding protein with appropriate affinity for calcium sensing\", \"pmid\": \"7527111\"},\n        {\"claim\": \"Trehalose induces ER stress and alters calcium homeostasis\", \"pmid\": \"30335591\"},\n        {\"claim\": \"Lysosome-associated calcium-binding proteins coordinate calcium release\", \"pmid\": \"31722219\"}\n      ],\n      \"evidence_against\": [\n        {\"claim\": \"RCN2 myristoylation targets plasma membrane, not lysosomes\", \"pmid\": \"25446908\"},\n        {\"claim\": \"RCN2 knockdown phenotypes are mild with minimal impact on calcium homeostasis\", \"pmid\": \"\"},\n        {\"claim\": \"Functional redundancy with calumenin, CAB39, and other EF-hand proteins likely compensates\", \"pmid\": \"\"},\n        {\"claim\": \"No clear trafficking mechanism proposed for ER-to-lysosome translocation\", \"pmid\": \"\"}\n      ]\n    }\n  ],\n  \"knowledge_edges\": [\n    {\"source_id\": \"H1_TRPML1\", \"source_type\": \"hypothesis\", \"target_id\": \"MCOLN1\", \"target_type\": \"gene\", \"relation\": \"proposes_direct_channel_activation\"},\n    {\"source_id\": \"H1_TRPML1\", \"source_type\": \"hypothesis\", \"target_id\": \"PPP3CA\", \"target_type\": \"gene\", \"relation\": \"requires_sequential_activation\"},\n    {\"source_id\": \"H1_TRPML1\", \"source_type\": \"hypothesis\", \"target_id\": \"CALM1\", \"target_type\": \"gene\", \"relation\": \"intermediate_sensor_required\"},\n    {\"source_id\": \"H3_CALM\", \"source_type\": \"hypothesis\", \"target_id\": \"CALM1\", \"target_type\": \"gene\", \"relation\": \"primary_target\"},\n    {\"source_id\": \"H3_CALM\", \"source_type\": \"hypothesis\", \"target_id\": \"PPP3CA\", \"target_type\": \"gene\", \"relation\": \"downstream_activation\"},\n    {\"source_id\": \"H3_CALM\", \"source_type\": \"hypothesis\", \"target_id\": \"CAMK2A\", \"target_type\": \"gene\", \"relation\": \"competing_pathway\"},\n    {\"source_id\": \"H4_mTORC1\", \"source_type\": \"hypothesis\", \"target_id\": \"MTOR\", \"target_type\": \"gene\", \"relation\": \"inhibition_required\"},\n    {\"source_id\": \"H4_mTORC1\", \"source_type\": \"hypothesis\", \"target_id\": \"TFEB\", \"target_type\": \"gene\", \"relation\": \"substrate_availability\"},\n    {\"source_id\": \"H4_mTORC1\", \"source_type\": \"hypothesis\", \"target_id\": \"PPP3CA\", \"target_type\": \"gene\", \"relation\": \"coincident_activation_required\"},\n    {\"source_id\": \"H2_RCN2\", \"source_type\": \"hypothesis\", \"target_id\": \"RCN2\", \"target_type\": \"gene\", \"relation\": \"scaffold_translocation\"},\n    {\"source_id\": \"H2_RCN2\", \"source_type\": \"hypothesis\", \"target_id\": \"PPP3R1\", \"target_type\": \"gene\", \"relation\": \"recruits_to_lysosome\"},\n    {\"source_id\": \"SKEPTIC\", \"source_type\": \"critique\", \"target_id\": \"H2_RCN2\", \"target_type\": \"hypothesis\", \"relation\": \"weakens_via_plasma_membrane_targeting\"},\n    {\"source_id\": \"SKEPTIC\", \"source_type\": \"critique\", \"target_id\": \"H1_TRPML1\", \"target_type\": \"hypothesis\", \"relation\": \"weakens_via_channel_redundancy\"},\n    {\"source_id\": \"DOMAIN_EXPERT\", \"source_type\": \"feasibility_assessment\", \"target_id\": \"H1_TRPML1\", \"target_type\": \"hypothesis\", \"relation\": \"confirms_druggability_high\"},\n    {\"source_id\": \"DOMAIN_EXPERT\", \"source_type\": \"feasibility_assessment\", \"target_id\": \"H2_RCN2\", \"target_type\": \"hypothesis\", \"relation\": \"confirms_druggability_low\"},\n    {\"source_id\": \"H1_TRPML1\", \"source_type\": \"hypothesis\", \"target_id\": \"ATP6V1A\", \"target_type\": \"gene\", \"relation\": \"upstream_vATPase_dependency\"},\n    {\"source_id\": \"H4_mTORC1\", \"source_type\": \"hypothesis\", \"target_id\": \"ATP6V1A\", \"target_type\": \"gene\", \"relation\": \"vATPase_inhibition_causal\"}\n  ],\n  \"synthesis_summary\": \"The debate converges on three viable mechanistic frameworks for trehalose-induced calcineurin specificity, with TRPML1-associated calcium microdomains (H1) emerging as the highest-priority hypothesis based on its superior druggability profile (existing agonists/antagonists, validated targets) and coherent spatiotemporal logic, despite the skeptic's valid concerns about channel redundancy requiring triple-knockout falsification. The mTORC1 dissociation hypothesis (H4) offers a complementary substrate-availability model with existing therapeutic precedent, while the calmodulin isoform availability model (H3) addresses the biochemical specificity question but faces druggability constraints due to calmodulin's essential ubiquitous expression. The reticulocalbin-2 hypothesis (H2) is effectively deprioritized by convergent skeptic-domain expert consensus, as its mechanistic foundations are undermined by plasma membrane targeting evidence and extensive functional redundancy among EF-hand proteins, offering no viable pharmacologic intervention point within a reasonable development timeline.\"\n}\n```",
  "tokens_used": "2756",
  "persona_id": "persona-synthesizer"
}